RedHill Biopharma Ltd. (RDHL)
0.345
0.00 (0.00%)
USD |
NASDAQ |
Nov 18, 16:00
0.345
0.00 (0.00%)
After-Hours: 20:00
RedHill Biopharma Enterprise Value : -11.74M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | -11.74M |
| November 16, 2026 | -11.68M |
| November 13, 2026 | -11.59M |
| November 12, 2026 | -11.55M |
| November 11, 2026 | -11.64M |
| November 10, 2026 | -11.59M |
| November 09, 2026 | -11.47M |
| November 06, 2026 | -11.27M |
| November 05, 2026 | -11.28M |
| November 04, 2026 | -11.30M |
| November 03, 2026 | -11.34M |
| November 02, 2026 | -11.18M |
| October 30, 2026 | -11.51M |
| October 29, 2026 | -11.34M |
| October 28, 2026 | -11.27M |
| October 27, 2026 | -11.14M |
| October 26, 2026 | -11.34M |
| October 23, 2026 | -11.30M |
| October 22, 2026 | -11.30M |
| October 21, 2026 | -11.10M |
| October 20, 2026 | -10.78M |
| October 19, 2026 | -10.82M |
| October 16, 2026 | -10.95M |
| October 15, 2026 | -10.83M |
| October 14, 2026 | -10.91M |
| Date | Value |
|---|---|
| October 13, 2026 | -10.74M |
| October 12, 2026 | -10.63M |
| October 09, 2026 | -10.59M |
| October 08, 2026 | -10.36M |
| October 07, 2026 | -10.99M |
| October 06, 2026 | -10.93M |
| October 05, 2026 | -10.87M |
| October 02, 2026 | -10.83M |
| October 01, 2026 | -10.95M |
| September 30, 2026 | -10.95M |
| September 29, 2026 | -10.94M |
| September 28, 2026 | -10.80M |
| September 25, 2026 | -10.83M |
| September 24, 2026 | -10.71M |
| September 23, 2026 | -10.57M |
| September 22, 2026 | -10.58M |
| September 21, 2026 | -10.53M |
| September 18, 2026 | -10.41M |
| September 17, 2026 | -10.26M |
| September 16, 2026 | -10.53M |
| September 15, 2026 | -10.37M |
| September 14, 2026 | -10.14M |
| September 11, 2026 | -9.948M |
| September 10, 2026 | -9.897M |
| September 09, 2026 | -9.635M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 62.64B |
| MediWound Ltd. | 158.09M |
| Purple Biotech Ltd. | -3.262M |
| Sol-Gel Technologies Ltd. | 129.48M |
| PolyPid Ltd. | 123.72M |
Enterprise Value Related Metrics
| Earnings Yield | -817.7% |
| Normalized Earnings Yield | -819.77 |